Loading
A phase 2 trial of Teniposide and Cisplatin in Germ cell tumours of childhood and adolescence, run by Chengcheng Guo, now recruiting.
Treatment of Newly Diagnosed Central Malignant Germ Cell Tumor People With Teniposide Injection Combined With Cisplatin is a phase 2 interventional study registered as NCT07188441 by Chengcheng Guo, with 40 participants planned, started 2024-08-13 and due to reach its primary completion in 2026-12. Interventions recorded: Teniposide Injection. Conditions recorded: GCT, Germ Cell Tumor, Central Malignant Germ Cell Tumor.
Linked to the drug Teniposide because the registry names it among its interventions and Germ cell tumours of childhood and adolescence among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Teniposide, Cisplatin and the tag pipeline.
Shares Cisplatin and the tag pipeline.
Shares Cisplatin and the tag pipeline.
Shares Cisplatin and the tag pipeline.
Shares Cisplatin and the tag pipeline.
Shares Cisplatin and the tag pipeline.
Shares Cisplatin and the tag pipeline.
Shares Cisplatin and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/